Sodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data
Caroline Fairhurst, Fabiola Martin, Ian Watt, Martin Bland, Tim Doran, View ORCID ProfileWilliam J. Brackenbury
doi: https://doi.org/10.1101/2022.12.16.22283520
Caroline Fairhurst
1Department of Health Sciences, University of York, UK
Fabiola Martin
2School of Public Health, University of Queensland, Australia
Ian Watt
1Department of Health Sciences, University of York, UK
Martin Bland
1Department of Health Sciences, University of York, UK
Tim Doran
1Department of Health Sciences, University of York, UK
William J. Brackenbury
3York Biomedical Research Institute, Department of Biology, University of York, UK
Posted January 18, 2023.
Sodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data
Caroline Fairhurst, Fabiola Martin, Ian Watt, Martin Bland, Tim Doran, William J. Brackenbury
medRxiv 2022.12.16.22283520; doi: https://doi.org/10.1101/2022.12.16.22283520
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2971)
- Dermatology (253)
- Emergency Medicine (446)
- Epidemiology (12820)
- Forensic Medicine (12)
- Gastroenterology (831)
- Genetic and Genomic Medicine (4624)
- Geriatric Medicine (424)
- Health Economics (733)
- Health Informatics (2944)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4414)
- Nursing (238)
- Nutrition (653)
- Oncology (2298)
- Ophthalmology (653)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (84)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (503)
- Public and Global Health (7010)
- Radiology and Imaging (1548)
- Respiratory Medicine (921)
- Rheumatology (445)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)